Data Collective IV GP, LLC

Est. AUM

$55.95B

13F long equity, this entity only

Positions

Period

Mar 2026 (Q1)

SEC EDGAR

Mar 2026 (Q1)

#	Issuer	Class	Value	Shares	% Portfolio	Discretion
1	Evolv Technologies Holdings, Inc.	COM CL A	$27.77B	4590000	49.63%	SOLE
2	Recursion Pharmaceuticals, Inc.	CL A	$18.24B	5941120	32.60%	SOLE
3	Horizon Quantum Holdings Ltd	CL A ORD SHS	$8.04B	915198	14.38%	SOLE
4	Definium Therapeutics, Inc. (MindMed)	COM SHS	$1.90B	100350	3.39%	SOLE

Values in USD (reported in $thousands on 13F). Source: SEC EDGAR.